Kenyan Health Patient Information Leaflet
Therapeutic agent (verify pharmacological class)
Constipation; situations where straining in defecation should be minimized as experienced after a heart attack and surgery; adjunct in abdominal radiological procedure. Clinical selection for Sulfolax should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.
5-10 drops in one dose/day. Children: 2-5 drops in one dose/day before going to bed.
Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.
Store as labelled. Keep out of reach of children.